It will help you learn medical terms and concepts you may not have encountered before. Multiple myeloma bone disease is marked by severe dysfunction of both bone formation and resorption and serves as a model for understanding the regulation of osteoblasts obl and osteoclasts ocl. Pdl1pd1 pathway in the pathophysiology of multiple myeloma. The bone marrow contains stem cells that produce three types of blood cell. Myeloma is called multiple because it frequently involves multiple areas in the body. Understanding the pathogenesis of myeloma bone disease has allowed us to identify novel targets for treating the disease. Pdl1pd1 pathway in the pathophysiology of multiple. Herein, we provide an insight into the underlying pathogenesis of bone disease and discuss possible directions for future studies. Usually, the bones of the hands, feet, and lower parts of the arms and legs are not affected, preserving the function of these critical areas. Multiple myeloma early detection, diagnosis, and staging. Some people with multiple myeloma, especially those with early stages of the condition, have no concerning signs or symptoms.
Common manifestations include lytic lesions in bones causing pain, andor fractures, renal insufficiency, hypercalcemia, anemia, and recurrent infections. Myeloma cells inhibit your bodys ability to fight infections. Multiple myeloma diagnosis and treatment mayo clinic. Multiple myeloma is a hematological malignancy characterized by the accumulation of malignant plasma cells in the bone marrow and in the majority of cases, findings of monoclonal immunoglobulins. Multiple myeloma accounts for 1% of all cancers and approximately 10% of all hematologic malignancies. Multiple myeloma mm is a plasma cell malignancy in which monoclonal plasma cells proliferate in bone marrow, resulting in an overabundance of monoclonal paraprotein m protein, destruction of bone, and displacement of other hematopoietic cell lines. Pdf myeloma bone disease mbd is a devastating complication of multiple myeloma mm.
Malignanat b cell lymphoproliferative disorder of the marrow with plasma cell predominating. The multiple myelomainduced bone destruction is a result of the increased activity of osteoclasts that occurs adjacent to multiple myeloma cells. Multiple myeloma can also affect your bones, leading to bone pain, thinning bones and broken bones. It is characterized by a multifocal proliferation of clonal, longlived plasma cells within the bone marrow bm and associated skeletal destruction, serum monoclonal gammopathy, immune suppression, and endorgan sequelae. Whether you or a loved one are worried about developing multiple myeloma, have just been diagnosed, are going through treatment, or are trying to stay well after treatment, this detailed guide can help you find the answers you need. For understanding of the pathophysiology of multiple myeloma, features of the malignant clone and changes induced by the bonemarrow microenvironment are equally important. Plasma cells help you fight infections by making antibodies that recognize and attack germs.
Mar 12, 2016 multiple myeloma is a form of cancer that occurs due to abnormal and uncontrolled growth of plasma cells in the bone marrow. Plasma cells are a type of white blood cell found in bone marrow, which is the soft tissue inside most of your bones that produces. Minimal residual disease in multiple myeloma multiple myeloma pathophysiology and epidemiology multiple myeloma mm is a plasma cell malignancy in which abnormal, clonal plasma cells proliferate and accumulate within the bone marrow. Myeloma is a cancer of the plasma cells in the bone marrow. Mm patients develop osteolytic bone lesions that can cause pathologic fractures and. When present, the most common symptom is anemia, which can be associated with fatigue and shortness of breath. Apr 18, 20 multiple myeloma bone disease is marked by severe dysfunction of both bone formation and resorption and serves as a model for understanding the regulation of osteoblasts obl and osteoclasts ocl in cancer. More than 80% of mm patients suffer from destructive bony lesions, leading to pain, fractures, mobility issues. Early mortality after diagnosis of multiple myeloma.
Epidemiology and pathophysiology multiple myeloma accounts for 1. It is the second most commonly diagnosed hematologic malignancy with an annual incidence and prevalence in the united states of approximately 15,000 and approximately 45,000, respectively. Among the earliest genetic events are translocations of the. The bone marrow contains stem cells that produce three types. Multiple myeloma is one of the hematological illnesses that we see in addition to lymphomas and leukemias in non. Multiple myeloma and bone metastasis from solid tumors.
Bone destruction in mm results from increased osteoclast formation and activity that occur in close proximity to myeloma cells. Multiple myeloma is a form of cancer that occurs due to abnormal and uncontrolled growth of plasma cells in the bone marrow. Multiple myeloma mm is a fatal, malignant bcell neoplasm characterized by uncontrolled, destructive growth of mutated plasma cells within the bone marrow. Feb 27, 2019 multiple myeloma is a form of cancer that affects bone marrow, the spongy soft tissue that lies within the hollow centre of some bones. Age increases the risk of multiple myeloma as the disease is rarely seen in persons less than 40 years of age with the mean onset at age 60. Patients endure severe bone pain, pathologic fractures, hypercalcemia, and a markedly decreased quality of life. Some early cancers may have signs and symptoms that can be noticed, but that is not always the case. Symptoms and signs include anemia, skin lesions, weakness, and bone fractures. Multiple myeloma mm is a bcell malignancy characterized by the clonal proliferation of malignant plasma cells in the bone marrow. Epidemiology and pathophysiology of multiple myeloma. Multiple myeloma mm arises from postgerminal b cells in the lymph node, with immunoglobulin ig gene rearrangement, extensive somatic hypermutation, and class switching of immunoglobulin heavy chain igh genes, suggesting that the malignant plasma cells have undergone antigen selection.
Read about multiple myeloma prognosis, life expectancy, stages, treatment, diagnosis, and causes. Myelomas are slightly more common in males than in females and can affect any of the marrowcontaining bones, such as the skull, the flat. Myeloma bone disease is responsible for some of the most devastating complications of the disease. How a plasma cell is transformed into a myeloma cell is not completely understood, but there are many genetic changes present in a myeloma cell. Jatin shah, md, explains that there is no clear reason for why patients develop multiple myeloma, and so theres no clear risk factor. Among the earliest genetic events are translocations of the immunoglobulin heavychain gene. This activity is accompanied by suppressed osteoblast differentiation and activity, resulting in severely impaired bone formation and development of devastating osteolytic lesions. The plasma cells proliferate in the bone marrow and often results in extensive skeletal destruction with osteolytic lesions, osteopenia, andor pathologic fractures.
More than 80% of mm patients suffer from destructive. Multiple myeloma hematology and oncology merck manuals. Reduce the dose for patients with renal impairment. Abnormal antibody fragments are produced in multiple myeloma and are deposited in various organs, such as the kidneys. Mar 19, 2020 multiple myeloma, malignant proliferation of cells within the bone marrow that usually occurs during middle age or later and increases in occurrence with age. Myeloma ig heavy chain v region sequences reveal prior antigenic. If youre experiencing symptoms, treatment can help relieve pain, control complications of the disease, stabilize your condition and slow the progress of multiple myeloma. Dec 15, 2006 multiple myeloma mm is a plasma cell malignancy characterized by a high capacity to induce osteolytic bone lesions. Multiple myeloma, malignant proliferation of cells within the bone marrow that usually occurs during middle age or later and increases in occurrence with age.
What is the pathophysiology of multiple myeloma mm. Recently the biologic mechanism involved in the imbalance between osteoclast activation and osteoblast inhibition induced by multiple myeloma cells has begun to be clarified. Multiple myeloma mm is a plasma cell dyscrasia characterized by malignant proliferation of monoclonal plasma cells in the bone marrow. Multiple myeloma is the secondmost prevalent blood cancer 10% after nonhodgkins lymphoma.
Jan 11, 2016 myeloma classification monoclonal gammopathy of undetermined significance serum mprotein 3 gdl andor bone marrow plasma cells. Multiple myeloma mm is a debilitating malignancy that is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance mgus to plasma cell leukemia. The multiple myeloma induced bone destruction is a result of the increased activity of osteoclasts that occurs adjacent to multiple myeloma cells. Multiple myeloma affects slightly more men than women. Pathophysiology of multiple myeloma bone disease sciencedirect. There are three major forms of renal damage in patients with multiple myeloma. Myeloma bone disease mbd is a devastating complication of multiple myeloma mm. The patient handbook focuses on the questions and decisions that a newly diagnosed patient faces. Jan 12, 2018 multiple myeloma mm is a plasma cell dyscrasia characterized by malignant proliferation of monoclonal plasma cells in the bone marrow. Pathophysiology and diagnosis of multiple myeloma jatin shah, md, explains that there is no clear reason for why patients develop multiple myeloma, and so theres no clear risk factor. Find out how multiple myeloma is tested for, diagnosed, and staged. Multiple myeloma genetic and rare diseases information. Mm is preceded by an ageprogressive premalignant condition termed. Treating multiple myeloma if you are facing multiple myeloma, we can help you learn about the treatment options and possible side effects, and point you to information and services to help you in your cancer journey.
Learn more about the symptoms, causes, diagnosis, risk factors, and treatment of multiple myeloma. In addition, more than 200 leading myeloma researchers comprise the imfs international myeloma working group imwg, a research body that has developed myeloma guidelines that are followed around the world. Multiple myeloma dr harpreet singh bhatia dmch, ludhiana,punjab 2. The bone marrow microenvironment in myeloma includes osteoblasts obl, osteoclasts ocl, stromal cells, endothelial cells, and osteocytes. Multiple interactions within the bone marrow microenvironment in myeloma are responsible for the abnormal bone remodeling of multiple myeloma bone disease mmbd. Apr 06, 2020 early mortality after diagnosis of multiple myeloma. Plasma cells come from b lymphocytes, and produce antibodies immunoglobulins. Multiple myeloma mm is a plasma cell malignancy in which monoclonal plasma cells proliferate in bone marrow, resulting in an. Blood chemistry tests levels of blood creatinine, albumin, calcium, and other electrolytes will be checked. If you have multiple myeloma but arent experiencing any symptoms also known as smoldering multiple myeloma, you may not need. The most common finding is a low red blood cell count anemia2.
Multiple myeloma mm is a neoplasm of postgerminal center, terminally differentiated b cells. Etiology of multiple myeloma there are no known causes of multiple myeloma, except from underlying causes of all cancer disease. Multiple myeloma is a hematologic malignancy characterized by the clonal proliferation of plasma cells in the bone marrow and, usually, the presence of a monoclonal ig in the blood andor urine. Multiple myeloma is a cancer of plasma cells that produce monoclonal immunoglobulin and invade and destroy adjacent bone tissue. Multiple myeloma early detection, diagnosis, and staging 1. Multiple myeloma is the second most common type of blood cancer after leukemia. Myeloma, also called multiple myeloma, is a cancer of the plasma cells. Multiple myeloma mm is characterized by the neoplastic proliferation of plasma cells producing a monoclonal immunoglobulin. Multiple myeloma is a plasma cell malignancy characterized by the frequent development of osteolytic bone lesions. The bone marrow produces red blood cells, which carry oxygen throughout the body. Multiple myeloma merck manuals professional edition. Genetic factors and viral infection may also influence the risk of developing multiple myeloma. In myeloma, the cells grow too much, crowding out normal cells in the bone marrow that make red blood cells, platelets, and other white blood cells.
Bone destruction is a hallmark of multiple myeloma mm. The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma. Coadminister oral calcium supplements of 500 mg and a multiple vitamin. We hope that the information will be helpful to both healthcare professionals and patients. If there are too many myeloma cells in the bone marrow, some of these blood cell levels can be low. Multiple myeloma is a cancer that develops in the bone marrow, the spongy tissue found in the center of most bones. Multiple myeloma is cancer that starts in the bone marrows plasma cells. Multiple myeloma is a type of cancer that affects plasma cells. Multiple myeloma is a hematological malignancy characterized by the accumulation of malignant plasma cells in the bone marrow and in the majority of cases, findings of monoclonal immunoglobulins in the blood.
Multiple myeloma plasma cells, which originate from postfollicular b cells, are characterised by complex chromosomal aberrations. Multiple myeloma is a form of cancer that affects bone marrow, the spongy soft tissue that lies within the hollow centre of some bones. Keywords multiple myeloma, mgus, plasma cell development, myeloma cancer stem cell, bone marrow microenvironment, myeloma oncogenomics. Myelomas are slightly more common in males than in females and can affect any of the marrowcontaining bones, such as. Scribd is the worlds largest social reading and publishing site. Multiple myeloma is a cancer that forms in a type of white blood cell called a plasma cell. Every year 1 percent of the people with mgus in the united states develop multiple myeloma. New insights into the pathophysiology of multiple myeloma. More than 80% of mm patients suffer from destructive bony.
1497 454 1055 1320 793 145 742 956 1314 449 94 207 648 252 20 1179 1345 1522 1014 865 1018 1347 924 281 137 237 1334 1056 1093 101 673 1081 619 1042 462 414 758 42